Latent autoimmune diabetes in adults

From WikiMD's WELLNESSPEDIA

(Redirected from Insulin autoantibody)

Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's weight loss doctor NYC
Philadelphia GLP-1 weight loss and GLP-1 clinic NYC

Latent autoimmune diabetes in adults
Blue circle for diabetes
Synonyms LADA, Type 1.5 diabetes
Pronounce
Specialty Endocrinology
Symptoms Hyperglycemia, weight loss, fatigue, polyuria, polydipsia
Complications N/A
Onset Typically in adulthood
Duration Chronic
Types N/A
Causes Autoimmune disease
Risks Genetic predisposition, environmental factors
Diagnosis Blood test for autoantibodies, C-peptide levels
Differential diagnosis Type 1 diabetes, Type 2 diabetes
Prevention N/A
Treatment Insulin therapy, dietary management, exercise
Medication Insulin
Prognosis Progressive loss of beta cell function
Frequency 5-10% of diabetes mellitus cases in adults
Deaths N/A


Latent autoimmune diabetes in adults

Latent autoimmune diabetes in adults (LADA) is a form of diabetes mellitus type 1 that occurs in adulthood, often with a slower course of onset than type 1 diabetes diagnosed in juveniles.

Introduction[edit]

LADA is a form of Type 1 diabetes that is diagnosed in individuals who are older than the typical age of onset of type 1 diabetes. This form of diabetes is characterized by the presence of similar autoantibodies to those found in type 1 diabetes, but with a slower progression of beta cell destruction. This results in a form of type 1 diabetes that may initially be mistaken for Type 2 diabetes.

Symptoms[edit]

The symptoms of LADA are similar to those of other forms of diabetes, including frequent urination, excessive thirst, weight loss, and fatigue. However, because the onset of LADA is slower than that of juvenile type 1 diabetes, these symptoms may be less severe or noticeable at first.

Diagnosis[edit]

Diagnosis of LADA is typically made through a combination of clinical evaluation and laboratory testing. The presence of autoantibodies against glutamic acid decarboxylase (GAD) is a key marker for LADA.

Treatment[edit]

Treatment for LADA typically involves the use of insulin, similar to the treatment for type 1 diabetes. However, because the destruction of beta cells is slower in LADA, some individuals may initially be able to manage their blood glucose levels with lifestyle changes or oral medications.

See also[edit]

Stub icon

This WikiMD article can only be edited by registered and verified editors. You can log in or register.

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Retrieved from "https://wikimd.org/index.php?title=Latent_autoimmune_diabetes_in_adults&oldid=6549082#Autoantibodies"